Thiru Prasanna

463 total citations
17 papers, 322 citations indexed

About

Thiru Prasanna is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Thiru Prasanna has authored 17 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Thiru Prasanna's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetic factors in colorectal cancer (3 papers). Thiru Prasanna is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Genetic factors in colorectal cancer (3 papers). Thiru Prasanna collaborates with scholars based in Australia, France and United States. Thiru Prasanna's co-authors include Desmond Yip, Paul Craft, Sudha Rao, Laeeq Malik, Jane E. Dahlstrom, Catriona M. McNeil, Hodo Haxhimolla, Fan Wu, Robert Padbury and Louise Nott and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Thiru Prasanna

17 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thiru Prasanna Australia 10 198 99 88 71 65 17 322
Mengyi Lao China 9 215 1.1× 133 1.3× 66 0.8× 86 1.2× 105 1.6× 21 351
Kevin G. Greene United States 7 150 0.8× 101 1.0× 78 0.9× 22 0.3× 96 1.5× 12 336
Chloé Broudin France 9 101 0.5× 66 0.7× 58 0.7× 62 0.9× 32 0.5× 23 224
Shinya Ohara Japan 12 159 0.8× 115 1.2× 135 1.5× 152 2.1× 32 0.5× 29 376
Jianquan Hou China 7 124 0.6× 67 0.7× 33 0.4× 35 0.5× 175 2.7× 15 311
Shenhong Qu China 10 101 0.5× 76 0.8× 42 0.5× 48 0.7× 44 0.7× 58 290
Camilo Garcia France 3 147 0.7× 57 0.6× 29 0.3× 75 1.1× 75 1.2× 10 238
David Stroncek United States 4 83 0.4× 87 0.9× 29 0.3× 16 0.2× 99 1.5× 11 263
Daiyuan Ma China 10 139 0.7× 77 0.8× 60 0.7× 110 1.5× 65 1.0× 40 274

Countries citing papers authored by Thiru Prasanna

Since Specialization
Citations

This map shows the geographic impact of Thiru Prasanna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thiru Prasanna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thiru Prasanna more than expected).

Fields of papers citing papers by Thiru Prasanna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thiru Prasanna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thiru Prasanna. The network helps show where Thiru Prasanna may publish in the future.

Co-authorship network of co-authors of Thiru Prasanna

This figure shows the co-authorship network connecting the top 25 collaborators of Thiru Prasanna. A scholar is included among the top collaborators of Thiru Prasanna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thiru Prasanna. Thiru Prasanna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Prasanna, Thiru, Laeeq Malik, Robert McCuaig, et al.. (2022). A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED). Frontiers in Oncology. 12. 862427–862427. 14 indexed citations
2.
McCuaig, Robert, Kristine Hardy, Nabila Seddiki, et al.. (2020). Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch. Frontiers in Immunology. 11. 1228–1228. 49 indexed citations
3.
Prasanna, Thiru, Rachel Wong, Timothy Price, et al.. (2020). Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. Current Problems in Cancer. 45(1). 100637–100637. 13 indexed citations
4.
Wu, Fan, Robert McCuaig, Christopher R. Sutton, et al.. (2019). Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 20(12). 3080–3080. 13 indexed citations
5.
Prasanna, Thiru, Michael Boyer, Catriona M. McNeil, et al.. (2019). Rate of Cancer Progression as a Predictive Marker of Efficacy of Immunotherapy; an Analysis in Metastatic Non-Small-Cell Lung Cancer. Immunotherapy. 11(8). 657–665. 2 indexed citations
6.
Prasanna, Thiru, Rachel Wong, Timothy Price, et al.. (2019). Metastasectomy and BRAF mutation: An analysis of survival outcome in metastatic colorectal cancer.. Journal of Clinical Oncology. 37(15_suppl). 3531–3531. 3 indexed citations
7.
Prasanna, Thiru, Fan Wu, Kum Kum Khanna, et al.. (2018). Optimizing poly (ADP‐ribose) polymerase inhibition through combined epigenetic and immunotherapy. Cancer Science. 109(11). 3383–3392. 29 indexed citations
8.
Prasanna, Thiru, Youlia Kirova, S. Alran, et al.. (2018). Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery. Critical Reviews in Oncology/Hematology. 134. 10–21. 10 indexed citations
9.
Prasanna, Thiru, et al.. (2018). Isolated Immune-Related Pancreatic Exocrine Insufficiency Associated with Pembrolizumab Therapy. Immunotherapy. 10(3). 171–175. 18 indexed citations
10.
Overman, Michael J., Patricia LoRusso, John H. Strickler, et al.. (2018). Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).. Journal of Clinical Oncology. 36(15_suppl). 4123–4123. 58 indexed citations
11.
Prasanna, Thiru, Jane Beith, Steven Kao, Michael Boyer, & Catriona M. McNeil. (2018). Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials. Asia-Pacific Journal of Clinical Oncology. 14(3). 125–133. 6 indexed citations
12.
Prasanna, Thiru, Christos S. Karapetis, David Roder, et al.. (2018). The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncologica. 57(11). 1438–1444. 72 indexed citations
13.
14.
Lee, Margaret, Anna J. Lomax, Michael Ng, et al.. (2017). Treatment sequencing and outcomes in synchronous metastatic rectal cancer.. Journal of Clinical Oncology. 35(4_suppl). 750–750. 1 indexed citations
15.
Prasanna, Thiru, et al.. (2017). Massive fatal pulmonary haemorrhage during bevacizumab treatment following microwave ablation therapy for oligometastatic lung metastasis from rectal cancer. Interactive Cardiovascular and Thoracic Surgery. 26(3). 514–515. 3 indexed citations
16.
17.
Kanjanapan, Yada, et al.. (2015). The Challenge of Managing Adrenocortical Carcinoma: Two Case Studies. ANU Open Research (Australian National University). 2(3). 175–184. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengyi Lao Breakdown of academic impact, for papers by Kevin G. Greene Breakdown of academic impact, for papers by Chloé Broudin Breakdown of academic impact, for papers by Shinya Ohara Breakdown of academic impact, for papers by Jianquan Hou Breakdown of academic impact, for papers by Shenhong Qu Breakdown of academic impact, for papers by Camilo Garcia Breakdown of academic impact, for papers by David Stroncek Breakdown of academic impact, for papers by Daiyuan Ma
Rankless by CCL
2026